 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Surface Oncology Inc. (SURF)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-05 Purchase | 2020-02-07 4:05 pm | Surface Oncology Inc. | SURF | Goater Jeff CEO | 5,000 | $3.23 | $16,150 | 262,000 (Direct) | View |
| 2020-05-20 Sale | 2020-05-22 4:56 pm | Surface Oncology Inc. | SURF | New Enterprise Associates 14 L.P. NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. KERINS PATRICK J SANDELL SCOTT D Sonsini Peter W. 10% Owner | 420,000 | $3.6561 | $1,535,562 | 2,892,877 (Direct) | View |
| 2020-09-01 Sale | 2020-09-03 4:17 pm | Surface Oncology Inc. | SURF | EcoR1 Capital LLC 10% Owner | 332,780 | $7.1419 | $2,376,682 | 4,701,081 (Indirect) | View |
| 2020-10-14 Sale | 2020-10-16 8:02 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 4,000 | $10.05 | $40,200 | 101,000 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 595 | $10.05 | $5,980 | 100,405 (Direct) | View |
| 2020-12-11 Sale | 2020-12-15 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 1,405 | $10.05 | $14,120 | 99,000 (Direct) | View |
| 2020-12-15 Sale | 2020-12-17 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 1,000 | $10.48 | $10,480 | 98,000 (Direct) | View |
| 2020-12-17 Sale | 2020-12-21 1:32 pm | Surface Oncology Inc. | SURF | Atlas Venture Fund IX L.P. Atlas Venture Associates IX L.P. Atlas Venture Associates IX LLC 10% Owner | 1,700,000 | $18.1 | $30,770,001 | 2,945,453 (Direct) | View |
| 2020-12-17 Sale | 2020-12-21 1:32 pm | Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director | 1,700,000 | $18.1 | $30,770,001 | 2,945,453 (Indirect) | View |
| 2020-12-17 Sale(A) | 2020-12-21 3:35 pm | Surface Oncology Inc. | SURF | Atlas Venture Fund IX L.P. Atlas Venture Associates IX L.P. Atlas Venture Associates IX LLC 10% Owner | 1,700,000 | $8.1 | $13,770,001 | 2,945,453 (Direct) | View |
| 2020-12-17 Sale(A) | 2020-12-21 3:35 pm | Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director | 1,700,000 | $8.1 | $13,770,001 | 2,945,453 (Indirect) | View |
| 2021-01-14 Sale | 2021-01-15 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 9,000 | $12.02 | $108,150 | 89,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-05 Option Award | 2019-06-06 4:45 pm | N/A 2029-06-05 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 12,100 | $3.69 | 12,100 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-06 4:46 pm | N/A 2029-06-05 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 12,100 | $3.69 | 12,100 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-06 4:46 pm | N/A 2029-06-05 | Surface Oncology Inc. | SURF | Stelzer Laurie Director | 12,100 | $3.69 | 12,100 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 5:19 pm | N/A 2029-07-01 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 5,696 | $2.79 | 5,696 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 5:20 pm | N/A 2029-07-01 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 6,937 | $2.79 | 6,937 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 5:20 pm | N/A 2029-07-01 | Surface Oncology Inc. | SURF | MCDONOUGH GEOFF Director | 3,834 | $2.79 | 3,834 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 5:20 pm | N/A 2029-07-01 | Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director | 6,280 | $2.79 | 6,280 (Direct) | View |
| 2019-10-01 Option Award | 2019-10-03 4:26 pm | N/A 2029-10-01 | Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director | 14,965 | $1.17 | 14,965 (Direct) | View |
| 2019-10-01 Option Award | 2019-10-03 4:28 pm | N/A 2029-10-01 | Surface Oncology Inc. | SURF | Ibrahim Ramy Director | 24,200 | $1.17 | 24,200 (Direct) | View |
| 2019-10-01 Option Award | 2019-10-03 4:29 pm | N/A 2029-10-01 | Surface Oncology Inc. | SURF | MCDONOUGH GEOFF Director | 9,135 | $1.17 | 9,135 (Direct) | View |
| 2019-10-01 Option Award | 2019-10-03 4:31 pm | N/A 2029-10-01 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 16,531 | $1.17 | 16,531 (Direct) | View |
| 2019-10-01 Option Award | 2019-10-03 4:33 pm | N/A 2029-10-01 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 13,572 | $1.17 | 13,572 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A N/A | Surface Oncology Inc. | SURF | Goater Jeff CEO | 257,000 | $0 | 257,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | Goater Jeff CEO | 257,000 | $3.18 | 257,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 45,000 | $0 | 45,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 45,000 | $3.18 | 45,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A N/A | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 80,000 | $3.18 | 80,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A N/A | Surface Oncology Inc. | SURF | Dwyer Wendy Chief Business Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | Dwyer Wendy Chief Business Officer | 80,000 | $3.18 | 80,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:10 pm | N/A N/A | Surface Oncology Inc. | SURF | Palombella Vito J. Chief Scientific Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:10 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | Palombella Vito J. Chief Scientific Officer | 80,000 | $3.18 | 80,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:10 pm | N/A N/A | Surface Oncology Inc. | SURF | Nogelo Liisa I Chief Legal Officer | 80,000 | $0 | 90,000 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:10 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | Nogelo Liisa I Chief Legal Officer | 90,000 | $3.18 | 90,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:05 pm | N/A N/A | Surface Oncology Inc. | SURF | Dwyer Wendy Chief Business Officer | 5,000 | $1.7 | 85,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Shanafelt Armen Director 10% Owner | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | LYNCH DANIEL Director | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | MCDONOUGH GEOFF Director | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | GRAYZEL DAVID S. Director | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Stelzer Laurie Director | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Ibrahim Ramy Director | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 12,000 | $4.35 | 12,000 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 4,773 | $4.136 | 14,078 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 122 | $4.27 | 14,078 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A 2026-12-09 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 4,773 | $4.136 | 14,078 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A 2029-03-01 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 122 | $4.27 | 14,078 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 227 | $4.136 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 173 | $4.27 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 982 | $5.412 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 1 | $4.27 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A 2026-12-09 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 227 | $4.136 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A 2029-03-01 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 173 | $4.27 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A 2027-06-27 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 982 | $5.412 | 25,999 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A 2029-03-01 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 1 | $4.27 | 25,999 (Direct) | View |